Study explores the potential use of anti-thymic stromal lymphopoietin monoclonal antibody as an adjuvant in allergic immunotherapy

Professional, doctor. Scientist with microscope

A new study investigated the impact of a monoclonal anti-thymic stromal lymphopoietin (TSLP) antibody on subcutaneous allergen immunotherapy (SCIT) efficacy among patients with allergic rhinitis.


Flexible Sensors Measure Fit of Face Masks

Previous article

Fluid Dynamics of Tiny, Ancient Marine Animals

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News